Equities

Medincell SA

Medincell SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)11.36
  • Today's Change2.05 / 22.02%
  • Shares traded977.48k
  • 1 Year change+25.66%
  • Beta0.9213
Data delayed at least 15 minutes, as of Apr 17 2024 16:39 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • MEDCL:PAR trading volume exceeds daily average by +188.20%
  • MEDCL:PAR price reached a new 52-week high of 10.54 at 10:07 BST
  • MEDCL:PAR price moved over +11.28% to 10.36
  • MEDCL:PAR price falls below 50-day moving average to 9.14 at 10:00 BST
  • MEDCL:PAR price falls below 50-day moving average to 9.15 at 17:47 BST
  • MEDCL:PAR price rises above 15-day moving average to 10.36 at 10:07 BST

Key statistics

Medincell SA (MEDCL:PAR) set a new 52-week high during today's trading session when it reached 11.62. Over this period, the share price is up 25.94%.
52-week range
Today
5.25Nov 01 202311.62Apr 17 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open10.32
High11.62
Low9.92
Bid11.20
Offer11.42
Previous close11.36
Average volume140.49k
Shares outstanding29.07m
Free float14.72m
P/E (TTM)--
Market cap270.65m EUR
EPS (TTM)-1.02
EUR
Data delayed at least 15 minutes, as of Apr 17 2024 16:39 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.